Send the following on WhatsApp
Continue to Chat騰盛博藥在2022年美國感染性疾病周(IDWeek 2022)上公佈積極臨床數據,以支持當前新型HIV治療候選藥物的持續開發 https://geneonline.news/%e9%a8%b0%e7%9b%9b%e5%8d%9a%e8%97%a5%e5%9c%a82022%e5%b9%b4%e7%be%8e%e5%9c%8b%e6%84%9f%e6%9f%93%e6%80%a7%e7%96%be%e7%97%85%e5%91%a8%ef%bc%88idweek-2022%ef%bc%89%e4%b8%8a%e5%85%ac%e4%bd%88%e7%a9%8d/?variant=zh-cn